Analyzing Outcomes of Immune Checkpoint Blockade Plus Chemo in SCLC
Ashish Saxena, MD, explains the outcomes of the addition of immune checkpoint blockade to standard chemotherapy for patients with metastatic small cell lung cancer.
Immune Checkpoint Bloackade Leads SCLC Treatment
Ashish Saxena, MD, PhD, discusses the standard-of-care regimens use to treat patients with small cell lung cancer at every stage.